Aetna modified CPB 0253 for vocal cord paralysis and insufficiency treatments, effective September 26, 2025. Here's what billing teams need to know before claims go out the door.
Aetna, a CVS Health company, updated its coverage policy for vocal cord paralysis and insufficiency interventions under CPB 0253 Aetna system. This revision clarifies which injectable agents, surgical procedures, and diagnostic tools meet medical necessity — and which don't. Codes directly in play include CPT 31570, 31571, 31591, 31573, 31574, 64617, and laryngeal EMG codes 95873 and 95874. If your practice bills for laryngology, head and neck surgery, or post-thyroidectomy care, this update touches your book of business.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Vocal Cord Paralysis/Insufficiency Treatments |
| Policy Code | CPB 0253 |
| Change Type | Modified |
| Effective Date | September 26, 2025 |
| Impact Level | Medium |
| Specialties Affected | Otolaryngology (ENT), Head & Neck Surgery, General Surgery, Gastroenterology, Speech-Language Pathology |
| Key Action | Audit your charge capture for CPT 31570, 31591, 31573, 31574, and 64617 against the updated medical necessity criteria before billing claims with September 26, 2025 or later dates of service |
Aetna Vocal Cord Paralysis Coverage Criteria and Medical Necessity Requirements 2025
The Aetna vocal cord paralysis coverage policy under CPB 0253 covers nine distinct interventions — but each has specific conditions attached. Don't assume a covered procedure is covered for every clinical scenario. The type of paralysis (unilateral vs. bilateral), duration (temporary vs. permanent), and the specific injectable agent all determine whether a claim will pay.
Bulking agent injections meet medical necessity when you're treating unilateral vocal cord paralysis with an FDA-cleared agent such as calcium hydroxylapatite (Renu). Aetna supports this because the clinical evidence shows it improves vocal quality and reduces recurrent aspiration pneumonia. Bill these using CPT 31570 (direct laryngoscopy with injection into vocal cords) or 31571 (with operating microscope or telescope), depending on technique.
Medialization thyroplasty — also called type 1 thyroplasty or medialization laryngoplasty — is covered for vocal cord paralysis. CPT 31591 is the correct code here. Aetna specifically calls out that a Gore-Tex/silastic implant is considered medically necessary for this indication. Document the implant material in your operative note. Missing that detail is the kind of thing that triggers a claim denial on post-payment audit.
Medialization laryngoplasty with arytenoid adduction is covered for vocal cord paralysis as a combined procedure. CPT 31400 (arytenoidectomy or arytenoidopexy, external approach) is the relevant surgical code in this context.
Post-surgical steroid injection after microsurgical removal of vocal fold lesions is covered specifically to reduce postoperative inflammation and scar formation. CPT 31573 covers flexible laryngoscopy with therapeutic injections — this is one of its on-policy uses here.
Radiesse (calcium hydroxylapatite and hyaluronic acid gel) is covered for permanent vocal cord paralysis or insufficiency. This is a distinct indication from the short-term cases below — make sure your documentation specifies "permanent" if that's the clinical picture.
Autologous fat harvesting and injection for vocal cord paralysis or insufficiency is covered. CPT 15877 (suction-assisted lipectomy, trunk) is listed as a related code for the fat harvest component. Bill CPT 31574 for the injection augmentation side.
Cymetra or Restylane injections are covered, but only for short-term paralysis cases — specifically post-thyroidectomy unilateral paralysis where the recurrent laryngeal nerve is known to be intact. This is an important distinction. If you're billing Cymetra or Restylane for a permanent or long-term paralysis case, don't expect coverage under this policy.
Laryngeal EMG for evaluation of vocal fold paralysis is covered. CPT 95873 and 95874 are the add-on codes for electrical stimulation guidance and needle EMG guidance used alongside chemodenervation procedures like CPT 64617. These are listed as covered when selection criteria are met.
Interarytenoid augmentation with an injectable filler for posterior laryngeal clefts in infants is covered — but only after three months of failed conservative management, such as thickening of feedings. Document that conservative management trial in your records before billing. No documentation of the failed trial, no coverage.
The policy does not explicitly list prior authorization requirements within CPB 0253, but Aetna's standard precertification requirements may still apply depending on the member's plan. Check the specific plan before scheduling surgical procedures. If you're unsure, your billing consultant or authorization team should confirm prior auth requirements before the date of service.
Aetna Vocal Cord Paralysis Exclusions and Non-Covered Indications
Three codes appear in the "not covered" bucket under CPB 0253. Know these before you bill.
CPT 31590 — laryngeal reinnervation by neuromuscular pedicle — is not covered for the indications listed in this policy. Reinnervation procedures remain off the covered list here.
CPT 64553 — percutaneous implantation of neurostimulator electrodes for the cranial nerve (posterior cricoarytenoideus muscle) — is also not covered. This covers laryngeal pacing and electrical stimulation implants for vocal cord paralysis. Aetna's position is that the evidence doesn't support this for the listed indications.
CPT 76536 — ultrasound of soft tissues of the head and neck — is not covered under this policy for these indications. If you're using ultrasound to guide injections or evaluate the larynx in a vocal cord paralysis workup, don't bill 76536 expecting reimbursement under CPB 0253.
These exclusions matter because all three procedures are clinically reasonable in a vocal cord paralysis workup or treatment plan. Your ENT or head and neck surgeon may order them. Make sure your team knows not to include them on the claim without an alternative coverage path.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Bulking agent injection (FDA-cleared, e.g., calcium hydroxylapatite/Renu) for unilateral VCP | Covered | CPT 31570, 31571 | Must use FDA-cleared agent; document unilateral diagnosis |
| Medialization thyroplasty (type 1) for VCP | Covered | CPT 31591 | Gore-Tex/silastic implant is medically necessary for this indication |
| Medialization laryngoplasty with arytenoid adduction | Covered | CPT 31400 | Combined procedure; document both components |
| Steroid injection after microsurgical vocal fold lesion removal | Covered | CPT 31573 | For postoperative inflammation/scar reduction only |
| Radiesse (calcium hydroxylapatite + hyaluronic acid gel) for permanent VCP/insufficiency | Covered | CPT 31574 | Must document permanent paralysis/insufficiency |
| Autologous fat harvesting and injection for VCP/insufficiency | Covered | CPT 15877, 31574 | Document harvest site and injection site separately |
| Cymetra or Restylane for short-term unilateral VCP | Covered | CPT 31573, 31574 | Short-term cases only; recurrent laryngeal nerve must be intact (e.g., post-thyroidectomy) |
| Laryngeal EMG for vocal fold paralysis evaluation | Covered | CPT +95873, +95874 | Add-on codes; use with CPT 64617 |
| Interarytenoid augmentation for posterior laryngeal cleft (infants) | Covered | CPT 31570, 31574 | Requires documented 3-month failed conservative management trial |
| Laryngeal reinnervation by neuromuscular pedicle | Not Covered | CPT 31590 | Not covered for indications in CPB 0253 |
| Neurostimulator electrode implantation, cranial nerve (posterior cricoarytenoideus) | Not Covered | CPT 64553 | Not covered for indications in CPB 0253 |
| Head/neck soft tissue ultrasound | Not Covered | CPT 76536 | Not covered for these indications under CPB 0253 |
Aetna Vocal Cord Paralysis Billing Guidelines and Action Items 2025
Vocal cord paralysis billing has always required attention to clinical specificity. This updated policy makes that more true, not less. Here are the concrete steps your team needs to take now.
| # | Action Item |
|---|---|
| 1 | Audit your charge capture templates for CPT 31570, 31571, 31573, 31574, and 31591. Each of these codes maps to a specific clinical scenario under CPB 0253. A generic "vocal cord injection" charge without the supporting clinical context will hit a claim denial or audit trigger. Update your encounter forms and order sets to capture the specific indication — unilateral vs. permanent, injectable agent used, and approach. |
| 2 | Flag all post-thyroidectomy vocal cord paralysis cases for documentation review. Cymetra and Restylane coverage under this policy is narrow — short-term paralysis with an intact recurrent laryngeal nerve only. Your team should verify that operative notes from the thyroidectomy document nerve integrity before billing for these agents. This is exactly where claim denials happen. |
| 3 | Remove CPT 76536 from your standard vocal cord paralysis workup bundles. If your practice routinely bills ultrasound alongside laryngoscopy for these cases, stop. CPT 76536 is specifically excluded under CPB 0253. Bill it only if there's a separate covered indication with its own diagnosis code to support it. |
| 4 | Document the three-month conservative management trial for infant laryngeal cleft cases before billing interarytenoid augmentation. Aetna will look for this. "Failed conservative management" in the problem list isn't enough. Your records need to show what was tried, for how long, and why it didn't work. |
| 5 | Confirm prior authorization requirements with the specific member plan before scheduling surgical cases. CPB 0253 defines medical necessity criteria, but individual plan prior auth requirements sit on top of that. Medialization thyroplasty (CPT 31591) and arytenoid adduction (CPT 31400) are surgical procedures with real reimbursement exposure. Don't assume that meeting medical necessity criteria means you can skip prior auth verification. |
| 6 | Check that autologous fat harvest claims include both CPT 15877 and the appropriate injection code. The fat harvest is a separate billable procedure. If your billing team is only capturing the laryngeal injection code, you're leaving money on the table and creating a documentation mismatch. |
If your practice handles a high volume of post-thyroidectomy or laryngology cases, loop in your compliance officer before September 26, 2025. The specificity of the coverage criteria here creates real audit exposure if documentation doesn't match the billing.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Vocal Cord Paralysis Treatments Under CPB 0253
Covered CPT Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 31400 | CPT | Arytenoidectomy or arytenoidopexy, external approach |
| 31513 | CPT | Laryngoscopy, indirect; with vocal cord injection |
| 31570 | CPT | Laryngoscopy, direct, with injection into vocal cord(s), therapeutic |
| 31571 | CPT | Laryngoscopy, direct, with injection into vocal cord(s), with operating microscope or telescope |
| 31591 | CPT | Laryngoplasty, medialization, unilateral |
| 43192 | CPT | Esophagoscopy, rigid, transoral; with directed submucosal injection(s), any substance |
| 43201 | CPT | Esophagoscopy, flexible, transoral; with directed submucosal injection(s), any substance |
| 43236 | CPT | Esophagogastroduodenoscopy, flexible, transoral; with directed submucosal injection(s), any substance |
| 43253 | CPT | Esophagoscopy, rigid, transoral; with directed submucosal injection(s), any substance |
| 64617 | CPT | Chemodenervation of muscle(s); larynx, unilateral, percutaneous (e.g., for spasmodic dysphonia), including guidance |
| +95873 | CPT (add-on) | Electrical stimulation for guidance in conjunction with chemodenervation |
| +95874 | CPT (add-on) | Needle electromyography for guidance in conjunction with chemodenervation |
Not Covered CPT Codes for Indications Listed in CPB 0253
| Code | Type | Description | Reason |
|---|---|---|---|
| 31590 | CPT | Laryngeal reinnervation by neuromuscular pedicle | Not covered for indications listed in CPB 0253 |
| 64553 | CPT | Percutaneous implantation of neurostimulator electrodes; cranial nerve (posterior cricoarytenoideus muscle) | Not covered for indications listed in CPB 0253 |
| 76536 | CPT | Ultrasound, soft tissues of head and neck (e.g., thyroid, parathyroid, parotid), real time with image documentation | Not covered for indications listed in CPB 0253 |
Other CPT Codes Related to CPB 0253
These codes appear in the policy as related — they support billing for procedures connected to the VCP treatment episode (e.g., thyroidectomy as the underlying cause, fat harvest, flexible laryngoscopy approaches).
| Code | Type | Description |
|---|---|---|
| 15877 | CPT | Suction-assisted lipectomy; trunk (for autologous fat harvest) |
| 31573 | CPT | Laryngoscopy, flexible; with therapeutic injection(s) (e.g., chemodenervation agent or corticosteroid) |
| 31574 | CPT | Laryngoscopy, flexible; with injection(s) for augmentation (e.g., percutaneous, transoral), unilateral |
| 60210–60271 | CPT | Thyroidectomy procedures (related as underlying cause of post-surgical VCP) |
Note: The policy lists ICD-10-CM diagnosis codes as applicable to CPB 0253, but the specific codes were not published in the version captured here. Verify the current ICD-10 code set directly at the Aetna CPB 0253 source page before billing.
Get the Full Picture for CPT 31570
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.